281 related articles for article (PubMed ID: 26219523)
1. [Malignant head and neck melanoma: Part 2: Therapy].
Pföhler C; Vogt T; Müller CS
HNO; 2015 Aug; 63(8):593-602; quiz 603-4. PubMed ID: 26219523
[TBL] [Abstract][Full Text] [Related]
2. [Malignant melanoma in the area of the head and neck].
Schwipper V
Mund Kiefer Gesichtschir; 2000 May; 4 Suppl 1():S177-86. PubMed ID: 10938658
[TBL] [Abstract][Full Text] [Related]
3. Head and neck melanoma (excluding ocular melanoma): United Kingdom National Multidisciplinary Guidelines.
Ahmed OA; Kelly C
J Laryngol Otol; 2016 May; 130(S2):S133-S141. PubMed ID: 27841141
[TBL] [Abstract][Full Text] [Related]
4. (Neo)adjuvant systemic therapy for melanoma.
van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW
Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016.
Garbe C; Peris K; Hauschild A; Saiag P; Middleton M; Bastholt L; Grob JJ; Malvehy J; Newton-Bishop J; Stratigos AJ; Pehamberger H; Eggermont AM; ; ;
Eur J Cancer; 2016 Aug; 63():201-17. PubMed ID: 27367293
[TBL] [Abstract][Full Text] [Related]
6. [Management of hematologic systemic diseases and rare tumor entities with manifestations in the oromaxillofacial area].
Petrasch S
Mund Kiefer Gesichtschir; 1998 Jul; 2(4):172-80. PubMed ID: 9738365
[TBL] [Abstract][Full Text] [Related]
7. [Surgical and adjuvant drug therapy in head and neck cutaneous melanoma].
Hauschild A; Lischner S; Christophers E
Laryngorhinootologie; 2000 Jul; 79(7):428-33. PubMed ID: 11005097
[TBL] [Abstract][Full Text] [Related]
8. BRAF and MEK inhibition in melanoma.
Dossett LA; Kudchadkar RR; Zager JS
Expert Opin Drug Saf; 2015 Apr; 14(4):559-70. PubMed ID: 25648338
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study.
Fujisawa Y; Yoshino K; Kadono T; Miyagawa T; Nakamura Y; Fujimoto M
Br J Dermatol; 2014 Dec; 171(6):1493-500. PubMed ID: 24814962
[TBL] [Abstract][Full Text] [Related]
10. Hedgehog pathway inhibitor in combination with radiation therapy for basal cell carcinomas of the head and neck : First clinical experience with vismodegib for locally advanced disease.
Schulze B; Meissner M; Ghanaati S; Burck I; Rödel C; Balermpas P
Strahlenther Onkol; 2016 Jan; 192(1):25-31. PubMed ID: 26449347
[TBL] [Abstract][Full Text] [Related]
11. Evaluation and surgical management of melanoma of the head and neck.
Robinson J; Kupferman M
JAAPA; 2011 Apr; 24(4):37-8, 40. PubMed ID: 21534381
[No Abstract] [Full Text] [Related]
12. Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors.
Papaspyrou G; Garbe C; Schadendorf D; Werner JA; Hauschild A; Egberts F
Melanoma Res; 2011 Dec; 21(6):475-82. PubMed ID: 21897303
[TBL] [Abstract][Full Text] [Related]
13. An update on the current management of head and neck mucosal melanoma.
Green B; Elhamshary A; Gomez R; Rahimi S; Brennan PA
J Oral Pathol Med; 2017 Aug; 46(7):475-479. PubMed ID: 27864904
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma.
Carlos G; Anforth R; Clements A; Menzies AM; Carlino MS; Chou S; Fernandez-Peñas P
JAMA Dermatol; 2015 Oct; 151(10):1103-9. PubMed ID: 26200476
[TBL] [Abstract][Full Text] [Related]
15. Unusual tumors involving the head and neck region: case 1. Angiosarcoma of the scalp.
Fakih MG; Defrances MC; Ohori NP; Ramanathan RK
J Clin Oncol; 2001 Nov; 19(21):4173-4. PubMed ID: 11689586
[No Abstract] [Full Text] [Related]
16. [Adjuvant therapy and interdisciplinary follow-up care of conjunctival melanoma].
Heindl LM; Koch KR; Schlaak M; Mauch C; Cursiefen C
Ophthalmologe; 2015 Nov; 112(11):907-11. PubMed ID: 26502167
[TBL] [Abstract][Full Text] [Related]
17. MEK inhibitors and their potential in the treatment of advanced melanoma: the advantages of combination therapy.
Tran KA; Cheng MY; Mitra A; Ogawa H; Shi VY; Olney LP; Kloxin AM; Maverakis E
Drug Des Devel Ther; 2016; 10():43-52. PubMed ID: 26730180
[TBL] [Abstract][Full Text] [Related]
18. Case of angiosarcoma of the scalp successfully controlled by eribulin.
Wada N; Uchi H; Furue M
J Dermatol; 2018 Jan; 45(1):116-117. PubMed ID: 28186350
[No Abstract] [Full Text] [Related]
19. Cutaneous malignant melanoma of the head and neck.
Fisher SR
Laryngoscope; 1989 Aug; 99(8 Pt 1):822-36. PubMed ID: 2755292
[TBL] [Abstract][Full Text] [Related]
20. [Cutaneous malignant melanoma of head and neck--an update].
Shulman O; Silfen R; Amir A; Hauben DJ
Harefuah; 2001 Feb; 140(2):144-8. PubMed ID: 11242921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
